Repository logo
 
Publication

Effect of cycloartanes on reversal of multidrug resistance and apoptosis induction on mouse lymphoma cells

dc.contributor.authorMadureira, AM
dc.contributor.authorSpengler, G
dc.contributor.authorMolnar, A
dc.contributor.authorVarga, A
dc.contributor.authorMolnar, J
dc.contributor.authorAbreu, PM
dc.contributor.authorFerreira, MJU
dc.date.accessioned2015-12-30T10:17:06Z
dc.date.available2015-12-30T10:17:06Z
dc.date.issued2004
dc.description.abstractThe ability of fifteen cycloartanes, isolated from Euphorbia species, to reverse multidrug resistance (MDR) and apoptosis induction in L5178Y mouse lymphoma cells, including its multidrug-resistant subline, was studied by flow cytometry. Reversion of MDR was investigated using a standard functional assay with rhodamine 123 as a fluorescent substrate analogue. For the evaluation of apoptosis, the cells were stained with FITC-labeled annexin V and propidium iodide. The majority of the compounds were able to reverse MDR of the tested human MDR1 gene-transfected mouse lymphoma cells. Some of the compounds were able to induce moderate apoptosis in the PAR cell line, but this effect was less effective on multidrug-resistant cells. The results indicate that cycloartanes can be substrates of ABC transporters, which might compete with certain anticancer chemotherapeutics.
dc.formatapplication/pdf
dc.identifier.citationANTICANCER RESEARCH. - Vol. 24, n. 2B (MAR-APR 2004), p. 859-864
dc.identifier.issn0250-7005
dc.identifier.urihttp://hdl.handle.net/10451/20927
dc.language.isoeng
dc.publisherINT INST ANTICANCER RESEARCH
dc.subjectOncology
dc.titleEffect of cycloartanes on reversal of multidrug resistance and apoptosis induction on mouse lymphoma cells
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage864por
oaire.citation.startPage859por
oaire.citation.titleANTICANCER RESEARCHpor
oaire.citation.volumeVol. 24por
rcaap.rightsrestrictedAccess
rcaap.typearticle

Files